126 related articles for article (PubMed ID: 35165762)
1. Evolutionary History of TOPIIA Topoisomerases in Animals.
Moreira F; Arenas M; Videira A; Pereira F
J Mol Evol; 2022 Apr; 90(2):149-165. PubMed ID: 35165762
[TBL] [Abstract][Full Text] [Related]
2. Structural organization of the human TOP2A and TOP2B genes.
Lang AJ; Mirski SE; Cummings HJ; Yu Q; Gerlach JH; Cole SP
Gene; 1998 Oct; 221(2):255-66. PubMed ID: 9795238
[TBL] [Abstract][Full Text] [Related]
3. Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.
Sapetto-Rebow B; McLoughlin SC; O'Shea LC; O'Leary O; Willer JR; Alvarez Y; Collery R; O'Sullivan J; Van Eeden F; Hensey C; Kennedy BN
BMC Dev Biol; 2011 Nov; 11():71. PubMed ID: 22111588
[TBL] [Abstract][Full Text] [Related]
4. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
[TBL] [Abstract][Full Text] [Related]
5. High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.
Song JH; Kweon SH; Kim HJ; Lee TH; Min WS; Kim HJ; Kim YK; Hwang SY; Kim TS
Br J Cancer; 2012 Jun; 107(1):108-15. PubMed ID: 22627319
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.
Schindlbeck C; Mayr D; Olivier C; Rack B; Engelstaedter V; Jueckstock J; Jenderek C; Andergassen U; Jeschke U; Friese K
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1029-37. PubMed ID: 20052594
[TBL] [Abstract][Full Text] [Related]
7. Clarifying the Mechanism of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα and IIβ.
Keck JM; Conner JD; Wilson JT; Jiang X; Lisic EC; Deweese JE
Chem Res Toxicol; 2019 Oct; 32(10):2135-2143. PubMed ID: 31512855
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
Shapiro AB; Austin CA
Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
[TBL] [Abstract][Full Text] [Related]
10. Untangling the roles of TOP2A and TOP2B in transcription and cancer.
Uusküla-Reimand L; Wilson MD
Sci Adv; 2022 Nov; 8(44):eadd4920. PubMed ID: 36322662
[TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon.
Harkin LF; Gerrelli D; Gold Diaz DC; Santos C; Alzu'bi A; Austin CA; Clowry GJ
J Anat; 2016 Mar; 228(3):452-63. PubMed ID: 26612825
[TBL] [Abstract][Full Text] [Related]
13. Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.
Arivazhagan A; Kumar DM; Sagar V; Patric IR; Sridevi S; Thota B; Srividya MR; Prasanna K; Thennarasu K; Mondal N; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
J Neurooncol; 2012 Apr; 107(2):289-97. PubMed ID: 22102081
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu and TOPIIa expression in gastric cancer reflect disease severity.
Liu HQ; Zhang SL; Song S
Hepatogastroenterology; 2012 Jun; 59(116):1290-3. PubMed ID: 22281973
[TBL] [Abstract][Full Text] [Related]
15. Evolution of TOP1 and TOP1MT Topoisomerases in Chordata.
Moreira F; Arenas M; Videira A; Pereira F
J Mol Evol; 2023 Apr; 91(2):192-203. PubMed ID: 36651963
[TBL] [Abstract][Full Text] [Related]
16. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.
Trinh BQ; Ko SY; Barengo N; Lin SY; Naora H
Cancer Res; 2013 Jan; 73(2):1000-10. PubMed ID: 23222298
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance.
Kaplan E; Gündüz U
Biomed Pharmacother; 2012 Feb; 66(1):29-35. PubMed ID: 22285073
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.
Belluti S; Basile V; Benatti P; Ferrari E; Marverti G; Imbriano C
Cell Death Dis; 2013 Aug; 4(8):e756. PubMed ID: 23928695
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer.
Järvinen TA; Liu ET
Curr Cancer Drug Targets; 2006 Nov; 6(7):579-602. PubMed ID: 17100565
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
Atwal M; Lishman EL; Austin CA; Cowell IG
Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]